Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 310

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis

Open access
Heemskerk, A. Dorothee, Bang, Nguyen D., Mai, Nguyen T.H., Chau, Tran T.H., Phu, Nguyen H., Loc, Pham P., Chau, Nguyen V.V., Hien, Tran T., Dung, Nguyen H., Lan, Nguyen T.N., Lan, Nguyen H., Lan, Nguyen N., Phong, Le T., Vien, Nguyen N., Hien, Nguyen Q., Yen, Nguyen T.B., Ha, Dang T.M., Day, Jeremy N., Caws, Maxine, Merson, Laura, Thinh, Tran T.V., Wolbers, Marcel, Thwaites, Guy E., Farrar, Jeremy J. · 2016 · New England Journal of Medicine

Abstract

BACKGROUND: Tuberculous meningitis is often lethal. Early antituberculosis treatment and adjunctive treatment with glucocorticoids improve survival, but nearly one third of patients with the condition still die. We hypothesized that intensified antituberculosis treatment would enhance the killing of intracerebral Mycobacterium tuberculosis organisms and decrease the rate of death among patients. METHODS: We performed a randomized, double-blind, placebo-controlled trial involving human immunodeficiency virus (HIV)-infected adults and HIV-uninfected adults with a clinical diagnosis of tuberculous meningitis who were admitted to one of two Vietnamese hospitals. We compared a standard, 9-month antituberculosis regimen (which included 10 mg of rifampin per kilogram of body weight per day) with an intensified regimen that included higher-dose rifampin (15 mg per kilogram per day) and levofloxacin (20 mg per kilogram per day) for the first 8 weeks of treatment. The primary outcome was death by 9 months after randomization. RESULTS: A total of 817 patients (349 of whom were HIV-infected) were enrolled; 409 were randomly assigned to receive the standard regimen, and 408 were assigned to receive intensified treatment. During the 9 months of follow-up, 113 patients in the intensified-treatment group and 114 patients in the standard-treatment group died (hazard ratio, 0.94; 95% confidence interval, 0.73 to 1.22; P=0.66). There was no evidence of a significant differential effect of intensified treatment in the overall population or in any of the subgroups, with the possible exception of patients infected with isoniazid-resistant M. tuberculosis. There were also no significant differences in secondary outcomes between the treatment groups. The overall number of adverse events leading to treatment interruption did not differ significantly between the treatment groups (64 events in the standard-treatment group and 95 events in the intensified-treatment group, P=0.08). CONCLUSIONS: Intensified antituberculosis treatment was not associated with a higher rate of survival among patients with tuberculous meningitis than standard treatment. (Funded by the Wellcome Trust and the Li Ka Shing Foundation; Current Controlled Trials number, ISRCTN61649292.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1507062

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 310

Metadata

Authors
Heemskerk, A. D., Bang, N. D., Mai, N. T. H., Chau, T. T. H., Phu, N. H., Loc, P. P., Chau, N. V. V., Hien, T. T., Dung, N. H., Lan, N. T. N., Lan, N. H., Lan, N. N., Phong, L. T., Vien, N. N., Hien, N. Q., Yen, N. T. B., Ha, D. T. M., Day, J. N., Caws, M., Merson, L., Thinh, T. T. V., Wolbers, M., Thwaites, G. E., & Farrar, J. J.
Venue
New England Journal of Medicine
Published
2016-01-14
Volume
374
Issue
2
Pages
124-134
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2333921168
Cited by
310
References
27
FWCI
41.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis. https://app.cochat.ai/papers/10.1056/nejmoa1507062
The paper
Heemskerk, A. D., Bang, N. D., Mai, N. T. H., Chau, T. T. H., Phu, N. H., Loc, P. P., Chau, N. V. V., Hien, T. T., Dung, N. H., Lan, N. T. N., Lan, N. H., Lan, N. N., Phong, L. T., Vien, N. N., Hien, N. Q., Yen, N. T. B., Ha, D. T. M., Day, J. N., Caws, M., . . . Farrar, J. J. (2016). Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1507062

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.